Effect of Immune X on common colds in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a product called Immune X can help reduce the number of colds in healthy adults. If you've had at least two colds last winter, you might be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You need to have had at least two colds last winter.
- Your body mass index (BMI) must be between 18 and 30.
- You must be generally healthy and have no chronic respiratory conditions (like asthma or COPD).
- You must not have had a cold, COVID-19, or other infections recently.
- You must be willing to avoid certain medications and supplements during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a herbal blend can help people who catch colds frequently feel better faster and with less severe symptoms. You would take the herbal blend or a placebo (inactive treatment) and keep a record of any cold symptoms.
This trial tests Antiwei Granules for treating the common cold. It looks for adults aged 18 to 65 who started having cold symptoms within the past 48 hours and have a mild fever.
This trial tests whether taking ibuprofen (a pain reliever) together with loratadine (an allergy medicine) works better than either medicine alone for common cold symptoms like sneezing, runny nose, headache, and cough. It may help you feel better faster.
This trial tests whether a probiotic supplement can help improve immune health in teachers who often get upper respiratory infections (like colds). You might qualify if you are a teacher between 18 and 50 years old, get colds often, and are willing to stop taking other supplements or medications for colds during the study.
This study tests if a supplement from yeast (called yeast beta-glucan) can help prevent upper respiratory infections in young adults with persistent allergic rhinitis. Participants take the supplement and are followed to see if it reduces colds and other respiratory illnesses.
This trial tests whether an immune defense protein can help reduce upper respiratory infections (like colds) in people aged 60 and older. It may be a good fit if you get colds or flu-like symptoms several times each season.
Hear when a new Common Cold trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.